Table 4.

Predictors of admission length (ln transformation) in multivariable analysis adjusted for viral pathogen, age, and underlying comorbidities

	β coefficients	95% CI	P value
HRV/ENT versus RSV	0·4	0·06, 0·9	0·085
HRV versus FLU	0·6	0·1, 1·0	0·012
HRV versus others	0·07	−0·4, 0·5	0·781
Age	0·008	−0·03, 0·05	0·687
Cardiorespiratory	0·3	−0·1, 0·7	0·160
Prematurity	0·6	0·005, 1·1	0·052
Immunocompromised Metabolic	0·7	0·3, 1·0	<0·001

HRV/ENT, enterovirus/rhinovirus; RSV, respiratory syncytial virus; FLU, influenza; others: PIV, parainfluenza; hMPV, human meta-pneumovirus; ADV, adenovirus, coronaviruses, HBoV.

Values indicated in bold were considered as significant P < 0.05.